Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Pemmaraju, N., Sweet, K. L., Stein, A. S., Wang, E. S., Rizzieri, D. A., Vasu, S., Rosenblat, T. L., Brooks, C. L., Habboubi, N., Mughal, T. I., Kantarjian, H., Konopleva, M., & Lane, A. A. (2022). Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm. Journal of Clinical Oncology, 40(26), 3032–3036. https://doi.org/10.1200/jco.22.00034
Authors:
Naveen Pemmaraju
Hagop Kantarjian
Marina Konopleva
Kendra L. Sweet
Anthony S. Stein
Eunice S. Wang
David A. Rizzieri
Sumithira Vasu
Todd L. Rosenblat
Christopher L. Brooks
Nassir Habboubi
Tariq Mughal
Andrew A. Lane
Affiliated Authors:
Todd L. Rosenblat
Publication Type:
Article
Unique ID:
10.1200/JCO.22.00034
PMID:
Publication Date:
Data Source:
Web of Science

Record Created: